Cervicitis screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


Screening for the infectious causes of cervicitis is recommended according to the 2015 [[Sexually Transmitted Diseases]] Treatment Guidelines by the [[CDC]].<ref name=STD-guildline>{{cite web | title = 2015 Sexually Transmitted Diseases Treatment Guidelines (CDC) | url = http://www.cdc.gov/std/tg2015/screening-recommendations.htm }}</ref><ref name=Gonorrhea-recomm>Workowski KA, Bolan GA. Sexually transmitted diseases treat- ment guidelines, 2015. MMWR Recomm Rep 2015;64:60–68.</ref><ref name=abc> Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. CDC. http://www.cdc.gov/std/tg2015/screening-recommendations.htm. Accessed on January 6th, 2016</ref><ref name=cde> Screening recommendation for chlamydia. UPSTF. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia(2014). Acessed on September 8, 2016</ref>
Screening for the [[infectious]] causes of cervicitis is recommended according to the 2015 [[Sexually Transmitted Diseases]] Treatment Guidelines by the [[CDC]].<ref name=STD-guildline>{{cite web | title = 2015 Sexually Transmitted Diseases Treatment Guidelines (CDC) | url = http://www.cdc.gov/std/tg2015/screening-recommendations.htm }}</ref><ref name=Gonorrhea-recomm>Workowski KA, Bolan GA. Sexually transmitted diseases treat- ment guidelines, 2015. MMWR Recomm Rep 2015;64:60–68.</ref><ref name=abc> Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. CDC. http://www.cdc.gov/std/tg2015/screening-recommendations.htm. Accessed on January 6th, 2016</ref><ref name=cde> Screening recommendation for chlamydia. UPSTF. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia(2014). Acessed on September 8, 2016</ref>
 
Gonococcal and Chlamydial screening is recommended in sexually active women under 25 years of age, sexually active women aged 25 years and older if at increased risk, all pregnant women under 25 years of age and pregnant women aged 25 and older if at increased risk.
Gonococcal and Chlamydial screening is recommended in sexually active women under 25 years of age, sexually active women aged 25 years and older if at increased risk, all pregnant women under 25 years of age and pregnant women aged 25 and older if at increased risk.



Revision as of 19:44, 27 February 2017

Cervicitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cervicitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cervicitis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cervicitis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cervicitis screening

CDC on Cervicitis screening

Cervicitis screening in the news

Blogs on Cervicitis screening

Directions to Hospitals Treating Cervicitis

Risk calculators and risk factors for Cervicitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Screening for the infectious causes of cervicitis is recommended according to the 2015 Sexually Transmitted Diseases Treatment Guidelines by the CDC.[1][2][3][4]

Gonococcal and Chlamydial screening is recommended in sexually active women under 25 years of age, sexually active women aged 25 years and older if at increased risk, all pregnant women under 25 years of age and pregnant women aged 25 and older if at increased risk.

Screening

Screening for the infectious causes of cervicitis is recommended according to the 2015 Sexually Transmitted Diseases Treatment Guidelines by the CDC as follows:[1][2][3][4]

Chlamydia cervicitis

  • Sexually active women under 25 years of age.
  • Sexually active women aged 25 years and older if at increased risk.
  • Retest approximately 3 months after treatment.

In pregnant women as follows:

  • All pregnant women under 25 years of age.
  • Pregnant women, aged 25 and older if at increased risk.
  • Retest during the 3rd trimester for women under 25 years of age or at risk.

Individuals with HIV as follows:

  • For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter.
  • More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology.

Gonococcal cervicitis

Screening is recommended in high risk people as follows:

Sexually active women under 25 years of age All pregnant women under 25 years of age and older women if at increased risk Sexually active women age 25 years and older if at increased risk as follows:

  • Prior history of sexually transmitted infection
  • A new sexual partner
  • More than one sexual partner

A sexual partner with concurrent partners

  • A sexual partner who has a sexually transmitted infection

HIV infected women as follows:

  • For sexually active individuals, screen at first HIV evaluation, and at least annually
  • More frequent screening for might be appropriate depending on individual risk behaviors and the local epidemiology

Herpes Cervicitis

Screening is recommended in pregnant women. Cesarean delivery is recommneded in pregnant women with active lesion.

Other nongonococcal infections

There is no specific screening modality for trichomonas vaginalis,[5] Mycoplasma genitalium and bacterial vaginosis.

References

  1. 1.0 1.1 "2015 Sexually Transmitted Diseases Treatment Guidelines (CDC)".
  2. 2.0 2.1 Workowski KA, Bolan GA. Sexually transmitted diseases treat- ment guidelines, 2015. MMWR Recomm Rep 2015;64:60–68.
  3. 3.0 3.1 Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. CDC. http://www.cdc.gov/std/tg2015/screening-recommendations.htm. Accessed on January 6th, 2016
  4. 4.0 4.1 Screening recommendation for chlamydia. UPSTF. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia(2014). Acessed on September 8, 2016
  5. Seña AC, Bachmann LH, Hobbs MM (2014). "Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations". Expert Rev Anti Infect Ther. 12 (6): 673–85. doi:10.1586/14787210.2014.887440. PMID 24555561.


Template:WikiDoc Sources